Business   

Pfizer wins Lipitor patent case

NEW DELHI: Global pharma giant Pfizer on Friday said it had won a legal battle in Denmark in its ongoing patent litigation over anti-cholesterol drug, Lipitor, with Ranbaxy Laboratories. Eastern Division of the High Court in Copenhagen, Denmark had ruled in the company’s favour which challenged two of its patents covering atorvastatin, the active ingredient in Lipitor, Pfizer said in a statement. The decision, which is subject to possible appeal, prevents Ranbaxy from launching its generic product before November 2011.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Cabinet clears new Companies Bill, 2008
GDP growth dips to 7.9% in first quarter
States urged to join new pension system
OVL in talks with Russian firms
Pfizer wins Lipitor patent case
Shyam-Sistema JV gets pan-India spectrum
Reliance Money makes foray into Europe
RBI prescription to tackle inflation
‘Singur will resonate in India’s global image’
Sensex zooms 516 points
Exchange Rates
Bullion Rates
IDFC MF introduces Strategic Sector fund
Union Bank starts wealth management services
BHEL to tap Toshiba technology for transformer
Microchip Tech opens development centre
Calsoft inaugurates new facility
Valgen offers new ERP solution

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu